{
  "meta": {
    "disclaimer": "Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. We may limit or otherwise restrict your access to the API in line with our Terms of Service.",
    "terms": "https://open.fda.gov/terms/",
    "license": "https://open.fda.gov/license/",
    "last_updated": "2026-06-03",
    "results": {
      "skip": 0,
      "limit": 1,
      "total": 1
    }
  },
  "results": [
    {
      "status": "Ongoing",
      "city": "Naples",
      "state": "FL",
      "country": "United States",
      "classification": "Class II",
      "openfda": {
        "application_number": [
          "ANDA215421"
        ],
        "brand_name": [
          "LIRAGLUTIDE"
        ],
        "generic_name": [
          "LIRAGLUTIDE"
        ],
        "manufacturer_name": [
          "Lupin Pharmaceuticals, Inc."
        ],
        "product_ndc": [
          "70748-346"
        ],
        "product_type": [
          "HUMAN PRESCRIPTION DRUG"
        ],
        "route": [
          "SUBCUTANEOUS"
        ],
        "substance_name": [
          "LIRAGLUTIDE"
        ],
        "rxcui": [
          "897122"
        ],
        "spl_id": [
          "e829ecbe-8005-412e-a0a1-65b44265050f"
        ],
        "spl_set_id": [
          "0450d8a2-a88e-4849-9788-ed4f5246f223"
        ],
        "package_ndc": [
          "70748-346-02",
          "70748-346-03"
        ],
        "is_original_packager": [
          true
        ],
        "nui": [
          "N0000178480",
          "M0160181",
          "N0000020058"
        ],
        "pharm_class_epc": [
          "GLP-1 Receptor Agonist [EPC]"
        ],
        "pharm_class_cs": [
          "Glucagon-Like Peptide 1 [CS]"
        ],
        "pharm_class_moa": [
          "Glucagon-like Peptide-1 (GLP-1) Agonists [MoA]"
        ],
        "unii": [
          "839I73S42A"
        ]
      },
      "product_type": "Drugs",
      "event_id": "98809",
      "recalling_firm": "Lupin Pharmaceuticals Inc.",
      "address_1": "5801 Pelican Bay Blvd Ste 500",
      "address_2": "",
      "postal_code": "34108-2734",
      "voluntary_mandated": "Voluntary: Firm initiated",
      "initial_firm_notification": "Letter",
      "distribution_pattern": "Nationwide within U.S",
      "recall_number": "D-0541-2026",
      "product_description": "Liraglutide Injection, 18 mg/3 mL (6 mg/mL), Rx only, Manufactured for: Lupin Pharmaceuticals, Inc., Naples, FL 34108, Manufactured by: Lupin Limited, Nagpur 441108, INDIA, a) 2 Pens- NDC 70748-346-02; b) 3 Pens - NDC 70748-346-03.",
      "product_quantity": "217,621 pen injectors",
      "reason_for_recall": "Presence of particulate matter: a white thread-like structure in the cartridge",
      "recall_initiation_date": "20260424",
      "center_classification_date": "20260519",
      "report_date": "20260527",
      "code_info": "Lots: a) WB00097, WB00094, WB00088, Expires: Jul. 2027; WB00103, Expires: Oct. 2027; WC00016, Expires: Dec. 2027; b) WB00098, WB00092, WB00093, Expires: Jul. 2027; WB00104, WB00106, WB00105, Expires: Oct. 2027.",
      "more_code_info": ""
    }
  ]
}